Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Carlos Alban currently holds 5,544 shares of SpringWorks Therapeutics, Inc. (SWTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carlos Alban has been a net seller of SWTX stock. They have purchased $0 and sold $46.3M worth of shares.
Carlos Alban's most recent insider trade was on Mar 27, 2026, when they sold 1,980 shares at $0.00 per share.
Carlos Alban serves as Executive at SpringWorks Therapeutics, Inc. (SWTX). They have executed 122 insider transactions totaling $46.3M over their tenure at the company.
Carlos Alban holds the position of Executive at SpringWorks Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Carlos Alban has shown a selling trading pattern, with $0 in total purchases and $46.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Carlos Alban was on Nov 16, 2020, when they sold $11.6M worth of ABBV shares. This transaction involved 115,830 shares at $100.00 per share.
Carlos Alban currently owns 5,544 shares of SpringWorks Therapeutics, Inc. (SWTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Carlos Alban's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Carlos Alban has 122 Form 4 filings on record as an insider at SpringWorks Therapeutics, Inc..
Set alerts for Carlos Alban and 40,000+ other insiders.